Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$40.64$41.80
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 51.91B | 51.46B | 50.94B | 46.79B | 46.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.91B | 51.46B | 50.94B | 46.79B | 46.70B |
| Cost of Revenue | 9.18B | 9.80B | 9.10B | 8.79B | 8.30B |
| Gross Profit | 42.73B | 41.65B | 41.84B | 38.00B | 38.40B |
| SG&A Expenses | 9.78B | 10.08B | 10.41B | 10.61B | 10.84B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 315.70M | 58.72M | 25.80M | 7.23M | 53.86M |
| Total Operating Expenses | 27.00B | 27.72B | 27.31B | 27.02B | 25.67B |
| Operating Income | 24.91B | 23.74B | 23.63B | 19.76B | 21.03B |
| Income Before Tax | 22.55B | 23.24B | 24.20B | 19.69B | 19.44B |
| Income Tax Expenses | 4.91B | 5.05B | 5.24B | 4.24B | 4.15B |
| Earnings from Continuing Operations | 17.64K | 18.20K | 18.96K | 15.45K | 15.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.64B | 18.20B | 18.96B | 15.45B | 15.30B |
| EBIT | 24.91B | 23.74B | 23.63B | 19.76B | 21.03B |
| EBITDA | 26.80B | 25.66B | 25.56B | 21.67B | 22.80B |
| EPS Basic | 3.98 | 4.10 | 4.27 | 3.48 | 3.44 |
| Normalized Basic EPS | 3.58 | 3.49 | 3.48 | 2.84 | 2.95 |
| EPS Diluted | 3.97 | 4.09 | 4.26 | 3.47 | 3.44 |
| Normalized Diluted EPS | 3.58 | 3.48 | 3.48 | 2.84 | 2.94 |
| Average Basic Shares Outstanding | 17.72B | 17.76B | 17.78B | 17.78B | 17.78B |
| Average Diluted Shares Outstanding | 17.76B | 17.78B | 17.79B | 17.79B | 17.80B |
| Dividend Per Share | 1.82 | 1.82 | 1.81 | 1.81 | 1.70 |
| Payout Ratio | 45.83% | 44.74% | 42.93% | 49.09% | 49.60% |